The ABO blood group system revisited: A review and update

Immunohematology

Volumn 25, Issue 2, 2009, Pages 48-59

  Storry, Jill R ^a   Olsson, Martin L ^b  

^a University and Regional Laboratories   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

ABO; Allele; Antigen; Blood group; Genotype

Indexed keywords

BLOOD GROUP A ANTIBODY; BLOOD GROUP A ANTIGEN; BLOOD GROUP ANTIGEN; BLOOD GROUP B ANTIBODY; BLOOD GROUP B ANTIGEN; ERYTHROCYTE ANTIGEN;

BLOOD GROUP ABO SYSTEM; BLOOD TRANSFUSION; EVIDENCE BASED MEDICINE; GENOTYPE; HEMAGGLUTINATION TEST; HUMAN; MOLECULAR CLONING; MOLECULAR GENETICS; NOMENCLATURE; OPEN READING FRAME; PATIENT SAFETY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TRANSFUSION RELATED ACUTE LUNG INJURY; TREATMENT FAILURE;

ABO BLOOD-GROUP SYSTEM; BLOOD TRANSFUSION; GENE EXPRESSION REGULATION; HUMANS; ISOANTIBODIES; POLYMORPHISM, GENETIC; RECEPTORS, CELL SURFACE;

EID: 70349578974     PISSN: 0894203X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (115)

1. Camp FR, Ellis FR. Selected contributions to the literature of blood groups and immunology. Fort Knox, KY: US Army Medical Research Laboratory, 1966.
2. Watkins WM. Biochemistry and genetics of the ABO, Lewis and P blood group systems. In: Harris H, Hirschhorn K, eds. Advances in human genetics. New York: Plenum Press, 1980:1-136.
3. Clausen H, Hakomori S. ABH and related histo-blood group antigens; immunochemical differences in carrier isotypes and their distribution. Vox Sang 1989;56:1-20. (Pubitemid 19023824)
4. Yazer MH, Palcic MM. The importance of disordered loops in ABO glycosyltransferases. Transfus Med Rev 2005;19:210-216
5. Yamamoto F. Molecular genetics of ABO. Vox Sang 2000;78:91-103.
6. Chester MA, Olsson ML. The ABO blood group gene: a locus of considerable genetic diversity. Transfus Med Rev 2001;15:177-200. (Pubitemid 32703017)
7. Landsteiner K. Zur Kenntnis der antifermentativen, lytischen und agglutinierenden Wirkungen des Blutserums und der Lymphe. Zbl Bakt 1900;27:357-362
8. Landsteiner K. Über Agglutinationserscheinungen normalen Menschlichen Blutes. Wien Klin Wochenschr 1901;14:1132-1134
9. Decastello A, Sturli A. Ueber die isoagglutinine im gesunder und kranker menschen. Munch Med Wochenschrift 1902;49:1090-1095
10. Race RR, Sanger R. Blood groups in man. 6th ed. Oxford, UK: Blackwell Scientific Publications, 1975.
11. von Dungern E, Hirzsfeld L. Uber die gruppenspezifische strukturen des blutes III. Immun Forsch 2191;8:526-562
12. Mourant AE, Kope AC, Domaniewska K. The distribution of human blood groups and other polymorphisms. New York: Oxford University Press, 1976.
13. Roychoudhuri AK, Nei M. Human polymorphic genes world distribution. Oxford: Oxford University Press, 1988.
14. Lalueza-Fox C, Gigli E, de la Rasilla M, Fortea J, Rosas A, Bertranpetit J, Krause J. Genetic characterization of the ABO blood group in Neandertals. BMC Evol Biol 2008;8:342.
15. Crainic K, Durigon M, Oriol R. ABO tissue antigens of Egyptian mummies. Forensic Sci Int 1989;43:113-124 (Pubitemid 19275361)
16. Korchagina EY, Pochechueva TV, Obukhova PS, Formanovsky AA, Imberty A, Rieben R, Bovin NV. Design of the blood group AB glycotope. Glycoconj J 2005;22:127-133
17. Clausen H, Levery SB, Dabelsteen E, Hakomori S. Blood group ABH antigens: a new series of blood group A-associated structures (genetic regulation and tissue distribution). Transplant Proc 1987;19:4408-4412 (Pubitemid 18049628)
18. Svensson L, Rydberg L, de Mattos LC, Henry SM. Blood group A and A revisited: an immunochemical analysis. Vox Sang 2009;96:56-61.
19. Daniels GL, Fletcher A, Garratty G, et al. Blood group terminology 2004: from the International Society of Blood Transfusion committee on terminology for red cell surface antigens. Vox Sang 2004;87:304-316
20. Blumenfeld OO, Patnaik SK. Allelic genes of blood group antigens: a source of human mutations and cS-NPs documented in the Blood Group Antigen Gene Mutation Database. Hum Mutat 2004;23:8-16.
21. Epstein AA, Ottenberg R. Simple method of performing serum reactions. Proc N Y Pathol Soc 1908;8:117-123
22. von Dungern E, Hirszfeld L. Concerning heredity of group specific structures of blood. Transfusion 1962;2:70-72
23. Bernstein F. Zusammenfassande betrachtungen über die erblichen Blutstrukturen des Menschen. Z Indukt Abstamm u VererbLehre 1925;37:237-270
24. Crow JF. Felix Bernstein and the first human marker locus. Genetics 1993;133:4-7.
25. Ferguson-Smith MA, Aitken DA, Turleau C, de Grouchy J. Localisation of the human ABO: Np-1: AK-1 linkage group by regional assignment of AK-1 to 9q34. Hum Genet 1976;34:35-43.
26. Yamamoto F, Clausen H, White T, Marken J, Hakomori S. Molecular genetic basis of the histo-blood group ABO system. Nature 1990;345:229-233 (Pubitemid 20163053)
27. Yamamoto F, Marken J, Tsuji T, White T, Clausen H, Hakomori S. Cloning and characterization of DNA complementary to human UDP-GalNAc:Fuc-alpha1-2Ga1 alpha1-3GalNAc transferase (histo-blood group A transferase) mRNA. J Biol Chem 1990;265:1146-1151 (Pubitemid 20048910)
28. Clausen H, White T, Takio K, et al. Isolation to homogeneity and partial characterization of a histo-blood group A defined Fuc-alpha1-2Gal alpha1-3-N-acetylgalactosaminyltransferase from human lung tissue. J Biol Chem 1990;265:1139-1145 (Pubitemid 20048909)
29. Yamamoto F, McNeill PD, Hakomori S. Human histoblood group A2 transferase coded by A2 allele, one of the A subtypes, is characterized by a single base deletion in the coding sequence, which results in an additional domain at the carboxyl terminal. Biochem Biophys Res Commun 1992;187:366-374
30. Yamamoto F, McNeill PD, Hakomori S. Genomic organization of human histo-blood group ABO genes. Glycobiology 1995;5:51-58
31. Bennett EP, Steffensen R, Clausen H, Weghuis DO, van Kessel AG. Genomic cloning of the human histo-blood group ABO locus. Biochem Biophys Res Commun 1995;206:318-325
32. Kominato Y, Hata Y, Takizawa H, et al. Alternative promoter identified between a hypermethylated upstream region of repetitive elements and a CpG island in human ABO histo-blood group genes. J Biol Chem 2002;277:37936-37948
33. Hosseini-Maaf B, Smart E, Chester MA, Olsson ML. The Abantu phenotype in the ABO blood group system is due to a splice-site mutation in a hybrid between a new O1-like allelic lineage and the A2 allele. Vox Sang 2005;88:256-264 (Pubitemid 40704899)
34. Calafell F, Roubinet F, Ramirez-Soriano A, Saitou N, Bertranpetit J, Blancher A. Evolutionary dynamics of the human ABO gene. Hum Genet 2008;124:123-135
35. Roubinet F, Kermarrec N, Despiau S, Apoil PA, Dugoujon JM, Blancher A. Molecular polymorphism of O alleles in five populations of different ethnic origins. Immunogenetics 2001;53:95-104.
36. Olsson ML, Guerreiro JF, Zago MA, Chester MA. Molecular analysis of the O alleles at the blood group ABO locus in populations of different ethnic origin reveals novel crossing-over events and point mutations. Biochem Biophys Res Commun 1997;234:779-782
37. Yazer MH, Olsson ML. The O2 allele: questioning the phenotypic definition of an ABO allele. Immunohematology 2008;24:138-147
38. Hosseini-Maaf B, Irshaid NM, Hellberg A, et al. New and unusual O alleles at the ABO locus are implicated in unexpected blood group phenotypes. Transfusion 2005;45:70-81.
39. Seltsam A, Das GC, Wagner FF, Blasczyk R. Nondeletional ABO*O alleles express weak blood group A phenotypes. Transfusion 2005;45:359-365
40. Lee HJ, Barry CH, Borisova SN, et al. Structural basis for the inactivity of human blood group O2 glycosyltransferase. J Biol Chem 2005;280:525-529
41. Wagner FF, Blasczyk R, Seltsam A. Nondeletional ABO*O alleles frequently cause blood donor typing problems. Transfusion 2005;45:1331-1334 (Pubitemid 41647800)
42. Yazer MH, Hult AK, Hellberg A, Hosseini-Maaf B, Palcic MM, Olsson ML. Investigation into A antigen expression on O2 heterozygous group O-labeled red blood cell units. Transfusion 2008;48:1650-1657
43. x phenotype. Transfus Med 1998;8:231-238
44. Olsson ML, Irshaid NM, Hosseini-Maaf B, et al. Genomic analysis of clinical samples with serologic ABO blood grouping discrepancies: identification of 15 novel A and B subgroup alleles. Blood 2001;98:1585-1593
45. Yu LC, Twu YC, Chou ML, Chang CY, Wu CY, Lin M. Molecular genetic analysis for the B(3) allele. Blood 2002;100:1490-1492
46. Seltsam A, Gruger D, Just B, et al. Aberrant intracellular trafficking of a variant B glycosyltransferase. Transfusion 2008;48:1898-1905
47. Hosseini-Maaf B, Hellberg A, Chester MA, Olsson ML. An extensive PCR-ASP strategy for clinical ABO blood group genotyping that avoids potential errors caused by null, subgroup and hybrid alleles. Transfusion 2007;47:2110-2125
48. Olsson ML, Chester MA. Polymorphism and recombination events at the ABO locus: a major challenge for genomic ABO blood grouping strategies. Transfus Med 2001;11:295-313.
49. Procter J, Crawford J, Bunce M, Welsh KI. A rapid molecular method (polymerase chain reaction with sequence-specific primers) to genotype for ABO blood group and secretor status and its potential for organ transplants. Tissue Antigens 1997;50:475-483 [published erratum appears in Tissue Antigens 1998;51:319]. (Pubitemid 27458269)
50. Kominato Y, Tsuchiya T, Hata N, Takizawa H, Yamamoto F. Transcription of human ABO histo-blood group genes is dependent upon binding of transcription factor CBF/NF-Y to minisatellite sequence. J Biol Chem 1997;272:25890-25898 (Pubitemid 27438914)
51. Irshaid NM, Chester MA, Olsson ML. Allele-related variation in minisatellite repeats involved in the transcription of the blood group ABO gene. Transfus Med 1999;9:219-226
52. Yu LC, Chang CY, Twu YC, Lin M. Human histo-blood group ABO glycosyltransferase genes: different enhancer structures with different transcriptional activities. Biochem Biophys Res Commun 2000;273:459-466 (Pubitemid 30599008)
53. Seltsam A, Wagner FF, Grüger D, Gupta CD, Bade-Doeding C, Blasczyk R. Weak blood group B phenotypes may be caused by variations in the CCAAT-binding factor/NF-Y enhancer region of the ABO gene. Transfusion 2007;47:2330-2335
54. Twu YC, Hsieh CY, Yu LC. Expression of the histo-blood group B gene predominates in AB-genotype cells. Transfusion 2006;46:1988-1996
55. Thuresson B, Chester MA, Storry JR, Olsson ML. ABO transcript levels in peripheral blood and erythropoietic culture show different allele-related patterns independent of the CBF/NF-Y enhancer motif and multiple novel allele-specific variations in the 5′- and 3′-noncoding regions. Transfusion 2008;48:493-504. (Pubitemid 351294577)
56. Hata Y, Kominato Y, Yamamoto FI, Takizawa H. Characterization of the human ABO gene promoter in erythroid cell lineage. Vox Sang 2002;82:39-46. (Pubitemid 36806475)
57. Bianco T, Farmer BJ, Sage RE, Dobrovic A. Loss of red cell A, B, and H antigens is frequent in myeloid malignancies. Blood 2001;97:3633-3639
58. Hosoi E, Hirose M, Hamano S, Kuroda Y. Detection of histo-blood group ABO mRNA in human chronic myeloid leukemia cell lines using reverse transcription-polymerase chain reaction (RT-PCR). Cancer Lett 1998;133:191-196 (Pubitemid 29069044)
59. Bianco-Miotto T, Hussey DJ, Day TK, O'Keefe DS, Dobrovic A. DNA methylation of the ABO promoter underlies loss of ABO allelic expression in a significant proportion of leukemic patients. PLoS ONE 2009;4:e4788.
60. Chihara Y, Sugano K, Kobayashi A, et al. Loss of blood group A antigen expression in bladder cancer caused by allelic loss and/or methylation of the ABO gene. Lab Invest 2005;85:895-907. (Pubitemid 41021298)
61. Dabelsteen E, Gao S. ABO blood-group antigens in oral cancer. J Dent Res 2005;84:21-28 (Pubitemid 43822056)
62. Orntoft TF, Meldgaard P, Pedersen B, Wolf H. The blood group ABO gene transcript is down-regulated in human bladder tumors and growth-stimulated urothelial cell lines. Cancer Res 1996;56:1031-1036 (Pubitemid 26065396)
63. Kabat EA. Blood group substances. Their chemistry and immunohistochemistry. New York: Academic Press, 1956.
64. Morgan WT, Watkins WM. The detection of a product of the blood group O gene and the relationship of the so-called O-substance to the agglutinates A and B. Br J Exp Pathol 1948;29:159-173
65. Morgan WT, Watkins WM. The inhibition of the haemagglutinins in plant seeds by human blood group substances and simple sugars. Br J Exp Pathol 1953;34:94-103.
66. Watkins WM, Morgan WT. Inhibition by simple sugars of enzymes which decompose the blood-group substances. Nature 1955;175:676-677
67. Watkins WM, Morgan WT. Possible genetical pathways for the biosynthesis of blood group mucopolysaccharides. Vox Sang 1959;4:97-119.
68. Ceppellini R. Physiological genetics of human blood group factors. In: Wolstenholme GEW, O'Connor CM, eds. Ciba Foundation symposium on biochemistry of human genetics. London: Churchill, 1959:242-261
69. Leloir LF. Nucleoside diphosphate sugars and saccharide synthesis. Biochem J 1964;91:1-8.
70. Watkins WM. Gene-enzyme relationships of the A, B, H and Le blood group genes (abstract). Transfusion 1967;7:367.
71. Hearn VM, Smith ZG, Watkins WM. An a-N-acetyl-D-galactosaminyltransferase associated with the human blood-group A character. Biochem J 1968;109:315-317
72. Race C, Ziderman D, Watkins WM. An alpha-d-galactosyltransferase associated with the blood-group B character. Biochem J 1968;107:733-735
73. Schenkel-Brunner H, Tuppy H. Enzymes from human gastric mucosa conferring blood-group A and B specificities upon erythrocytes. Eur J Biochem 1970;17:218-22.
74. Schachter H, Michaels MA, Tilley CA, Crookston MC, Crookston JH. Qualitative differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and A2 genes. Proc Natl Acad Sci U S A 1973;70:220-224
75. Topping MD, Watkins WM. Isolectric points of the human blood group A-1, A-2 and B gene- associated glycosyltransferases in ovarian cyst fluids and serum. Biochem Biophys Res Commun 1975;64:89-96.
76. Clausen H, Levery SB, Nudelman E, Tsuchiya S, Hakomori S. Repetitive A epitope (type 3 chain A) defined by blood group A1-specific monoclonal antibody TH-1: chemical basis of qualitative A1 and A2 distinction. Proc Natl Acad Sci U S A 1985;82:1199-1203
77. Varki A, Cummings R, Esko J, Freeze H, Hart G, Marth J. Essentials of glycobiology. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1999.
78. Oriol R, Candelier JJ, Mollicone R. Molecular genetics of H. Vox Sang 2000;78(Suppl 2):105-108
79. Paulson JC, Colley KJ. Glycosyltransferases. Structure, localization, and control of cell type-specific glycosylation. J Biol Chem 1989;264:17615-17618
80. Clausen H, Bennett EP, Dabelsteen E. Carbohydrates of the cell surface: molecular aspects of glycosyltransferases and their genes. APMIS Suppl 1992;27:9-17.
81. Patenaude SI, Seto NO, Borisova SN, et al. The structural basis for specificity in human ABO(H) blood group biosynthesis. Nat Struct Biol 2002;9:685-690
82. Hosseini-Maaf B, Letts JA, Persson M, et al. Structural basis for red cell phenotypic changes in newly identified, naturally occurring subgroup mutants of the human blood group B glycosyltransferase. Transfusion 2007;47:864-875 (Pubitemid 46669001)
83. Springer GF, Williamson P, Readler BL. Blood group active gram-negative bacteria and higher plants. Ann N Y Acad Sci 1962;97:104-110
84. Cooling LW, Sitwala K, Dake LR, Judd WJ, Davenport R. ABO typing discrepancies in children requiring long-term nutritional support: it is the gut after all! Transfusion 2007;47:10A.
85. Kunkel HG, Fudenberg H, Ovary Z. High molecular weight antibodies. Ann NY Acad Sci 1960;86:966-973
86. 2A and other immunoglobulins in isolated anti-A antibodies. Proc Soc Exp Biol Med 1963;113:278.
87. Garratty G. Blood group antigens as tumor markers, parasitic/bacterial/ viral receptors, and their association with immunologically important proteins. Immunol Invest 1995;24:213-232
88. Daniel-Johnson J, Lee-Stroka A, Schechterly C, et al. Probiotic-associated high-titer anti-B in a group A platelet donor as a cause of severe hemolytic transfusion reactions. Transfusion 2008;48S(Suppl 2):260A.
89. Arendrup M, Hansen JE, Clausen H, Nielsen C, Mathiesen LR, Nielsen JO. Antibody to histo-blood group A antigen neutralizes HIV produced by lymphocytes from blood group A donors but not from blood group B or O donors. AIDS 1991;5:441-444
90. Preece AF, Strahan KM, Devitt J, Yamamoto F, Gustafsson K. Expression of ABO or related antigenic carbohydrates on viral envelopes leads to neutralization in the presence of serum containing specific natural antibodies and complement. Blood 2002;99:2477-2482
91. Cserti CM, Dzik WH. The ABO blood group system and Plasmodium falciparum malaria. Blood 2007;110:2250-2258 (Pubitemid 47523142)
92. Uneke CJ. Plasmodium falciparum malaria and ABO blood group: is there any relationship? Parasitol Res 2007;100:759-765
93. Chen Q, Heddini A, Barragan A, Fernandez V, Pearce SF, Wahlgren M. The semiconserved head structure of Plasmodium falciparum erythrocyte membrane protein 1 mediates binding to multiple independent host receptors. J Exp Med 2000;192:1-10. (Pubitemid 30470801)
94. Loscertales MP, Owens S, O'Donnell J, Bunn J, Bosch-Capblanch X, Brabin BJ. ABO blood group phenotypes and Plasmodium falciparum malaria: unlocking a pivotal mechanism. Adv Parasitol 2007;65:1-50. (Pubitemid 350193231)
95. Rowe JA, Handel IG, Thera MA, et al. Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting. Proc Natl Acad Sci U S A 2007;104:17471-17476
96. Gagneux P, Varki A. Evolutionary considerations in relating oligosaccharide diversity to biological function. Glycobiology 1999;9:747-755 (Pubitemid 29376001)
97. Mollison PL, Engelfriet CP, Contreras M. Blood transfusion in clinical medicine. 10th ed. London: Blackwell Scientific, 1997.
98. Issitt PD, Anstee DJ. Applied blood group serology. 4th ed. Miami: Montgomery Scientific Publications, 1998.
99. Sazama K. Reports of 355 transfusion-associated deaths: 1976 through 1985. Transfusion 1990;30:583-590
100. Stainsby D, Jones H, Asher D, et al. Serious hazards of transfusion: a decade of hemovigilance in the UK. Transfus Med Rev 2006;20:273-282 (Pubitemid 44428107)
101. Linden JV, Wagner K, Voytovich AE, Sheehan J. Transfusion errors in New York State: an analysis of 10 years' experience. Transfusion 2000;40:1207-1213 (Pubitemid 30782916)
102. Shanwell A, Andersson TM, Rostgaard K, et al. Post-transfusion mortality among recipients of ABO-compatible but non-identical plasma. Vox Sang 2009;96:316-323
103. Blumberg N, Heal JM, Hicks GL Jr, Risher WH. Association of ABO-mismatched platelet transfusions with morbidity and mortality in cardiac surgery. Transfusion 2001;41:790-793 (Pubitemid 32538515)
104. Romano EL, Soyano A, Montano RF, et al. Treatment of ABO hemolytic disease with synthetic blood group trisaccharides. Vox Sang 1994;66:194-199 (Pubitemid 24103655)
105. Rydberg L. ABO-incompatibility in solid organ transplantation. Transfus Med 2001;11:325-342 (Pubitemid 32771925)
106. West LJ, Pollock-Barziv SM, Dipchand AI, et al. ABO-incompatible heart transplantation in infants. N Engl J Med 2001;344:793-800.
107. West LJ. B-cell tolerance following ABO-incompatible infant heart transplantation. Transplantation 2006;81:301-307
108. Tobian AA, Shirey RS, Montgomery RA, Tisch DJ, Ness PM, King KE. Therapeutic plasma exchange reduces ABO titers to permit ABO-incompatible renal transplantation. Transfusion 2009 Feb 6 [Epub ahead of print].
109. Yazer MH, Triulzi DJ. Immune hemolysis following ABO-mismatched stem cell or solid organ transplantation. Curr Opin Hematol 2007;14:664-670
110. Avent ND, Martinez A, Flegel WA, et al. The BloodGen project: toward mass-scale comprehensive genotyping of blood donors in the European Union and beyond. Transfusion 2007;47(Suppl):40S-6S. (Pubitemid 46934293)
111. Kline TR, Runyon MK, Pothiawala M, Ismagilov RF. ABO, D blood typing and subtyping using plug-based microfluidics. Anal Chem 2008;80:6190-6197
112. Goldstein J, Siviglia G, Hurst R, Lenny L, Reich L. Group B erythrocytes enzymatically converted to group O survive normally in A, B, and O individuals. Science 1982;215:168-170 (Pubitemid 12178100)
113. Liu QP, Sulzenbacher G, Yuan H, et al. Bacterial glycosidases for the production of universal red blood cells. Nat Biotechnol 2007;25:454-464 (Pubitemid 46572854)
114. Olsson ML, Clausen H. Modifying the red cell surface: towards an ABO-universal blood supply. Br J Haematol 2008;140:3-12. (Pubitemid 350233244)
115. Liu QP, Yuan H, Bennett EP, et al. Identification of a GH110 subfamily of alpha 1,3-galactosidases: novel enzymes for removal of the alpha 3Gal xenotransplantation antigen. J Biol Chem 2008;283:8545-8554